Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18490274rdf:typepubmed:Citationlld:pubmed
pubmed-article:18490274lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0013516lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0178601lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0080310lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0012000lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0554756lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0546881lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0039155lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18490274lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:18490274pubmed:issue6lld:pubmed
pubmed-article:18490274pubmed:dateCreated2008-10-24lld:pubmed
pubmed-article:18490274pubmed:abstractTextErgot-derived dopamine agonists (EDDA) induce fibrotic heart valve disease. We aimed to investigate whether EDDA treatment also affects left ventricular (LV) function.lld:pubmed
pubmed-article:18490274pubmed:languageenglld:pubmed
pubmed-article:18490274pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18490274pubmed:citationSubsetIMlld:pubmed
pubmed-article:18490274pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18490274pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18490274pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18490274pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18490274pubmed:statusMEDLINElld:pubmed
pubmed-article:18490274pubmed:monthNovlld:pubmed
pubmed-article:18490274pubmed:issn1532-2114lld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:EgebladHenrik...lld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:OstergaardKar...lld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:DupontErikElld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:PoulsenSteen...lld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:RasmussenVibe...lld:pubmed
pubmed-article:18490274pubmed:authorpubmed-author:SafikhanyGhol...lld:pubmed
pubmed-article:18490274pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18490274pubmed:volume9lld:pubmed
pubmed-article:18490274pubmed:ownerNLMlld:pubmed
pubmed-article:18490274pubmed:authorsCompleteYlld:pubmed
pubmed-article:18490274pubmed:pagination803-8lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:meshHeadingpubmed-meshheading:18490274...lld:pubmed
pubmed-article:18490274pubmed:year2008lld:pubmed
pubmed-article:18490274pubmed:articleTitleErgotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking.lld:pubmed
pubmed-article:18490274pubmed:affiliationDepartment of Cardiology, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark.lld:pubmed
pubmed-article:18490274pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18490274pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18490274pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed